33933127Funk RS, Shakhnovich V, Cho YK, Polireddy K, Jausurawong T, Gress K, Becker MLPediatric rheumatology online journalArthritis, Juvenile; Autoimmune Diseases; Drug Monitoring; Inflammatory Bowel Diseases; Infliximab; UveitisAdolescent; Antibodies, Anti-Idiotypic; Cross-Sectional Studies; Dose-Response Relationship, Immunologic; Female; Humans; Male; Metabolic Clearance Rate; Pediatrics; Tumor Necrosis Factor Inhibitors; United StatesFunk RS, Shakhnovich V, Cho YK, Polireddy K, Jausurawong T, Gress K, Becker ML. Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study. Pediatr Rheumatol Online J. 2021 May 01; 19(1):62.Pediatr Rheumatol Online J2021-05-01T00:00:002021Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study.prns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAuthorshipvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedInformationResourcelinked information resourcerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptD008297Physiology11633280.54802MaleD008657PhenomenaPhysiologyProcedures6180.988803Metabolic Clearance RateD010372Occupations531750.832196PediatricsD014481Geographic Areas846560.814989United StatesD014605DisordersUveitisD015212Disorders16420.941477Inflammatory Bowel DiseasesD016903Procedures10190.983245Drug MonitoringD000069285470.995628InfliximabD000293Living Beings10621370.61882AdolescentD000888Chemicals & Drugs230.996442Antibodies, Anti-IdiotypicAuthorship 95290.4089680.4089681authors10.2516has subject areaD001171Disorders9300.953937Arthritis, JuvenileD001327Disorders6110.994359Autoimmune DiseasesD003430Concepts & IdeasProcedures683190.885885Cross-Sectional StudiesD004306Concepts & Ideas110.999784Dose-Response Relationship, ImmunologicD005260Physiology11835990.534568FemaleD006801Living Beings12067970.397999Humans